Biblio Discovery — Demo Discovery Service

5 results for "Demidem, Aicha"

Showing 1–5 · 0.09 seconds · RSS

  1. Journal Article Full text

    NMR metabolomics of fibroblasts with inherited mitochondrial Complex I mutation reveals treatment-reversible lipid and amino acid metabolism alterations

    Morvan, Daniel; Demidem, Aicha

    Metabolomics · 2018 · English · PubMed Central

    INTRODUCTION: Elucidating molecular alterations due to mitochondrial Complex I (CI) mutations may help to understand CI deficiency (CID), not only in mitochondriopathies but also as it is caused by drugs or associated to many diseases. OBJECTIVES: CID metabolic expression was investigated in…

  2. Journal Article

    A Model of Phospholipid Biosynthesis in Tumor in Response to an Anticancer Agent in Vivo

    Behzadi Mahsa; Demidem Aicha; Morvan Daniel et al.

    Journal of Integrative Bioinformatics, Vol. 7 No. 3 · 2010 · English · DOAJ Scopus

    We study, in this paper, a model for the core of the system of the Glycerophospholipid metabolism in the murine cells. It comprises the simple and enzymatic reactions of PhosphatidylEthanolamine and the PhosphatidylCholine . The model’s general structure is taken from a number of books and…

  3. Journal Article Full text

    Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity

    Buchard, Benjamin; Teilhet, Camille; Abeywickrama Samarakoon, Natali et al.

    Metabolites · 2021 · English · PubMed Central

    Non-Alcoholic Fatty Liver Disease (NAFLD) is considered as the forthcoming predominant cause for hepatocellular carcinoma (HCC). NAFLD-HCC may rise in non-cirrhotic livers in 40 to 50% of patients. The aim of this study was to identify different metabolic pathways of HCC according to fibrosis level…

  4. Journal Article Full text

    Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts (1)H-NMR Spectroscopy

    Teilhet, Camille; Morvan, Daniel; Joubert-Zakeyh, Juliette et al.

    Metabolites · 2017 · English · PubMed Central

    There is a rising incidence of non-alcoholic fatty liver disease (NAFLD) as well as of the frequency of Hepato-Cellular Carcinoma (HCC) associated with NAFLD. To seek for putative metabolic pathways specific of the NAFLD etiology, we performed comparative metabolomics between HCC associated with…

  5. Journal Article Full text

    Simultaneous Activation of Beta‐Oxidation and De Novo Lipogenesis in MASLD‐HCC: A New Paradigm

    Dahboul, Fatima; Sun, Jihan; Buchard, Benjamin et al.

    Liver Int · 2025 · English · PubMed Central

    BACKGROUND AND AIMS: Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common cause of hepatocellular carcinoma (HCC). In this study, we combine metabolomic and gene expression analysis to compare HCC tissues with non‐tumoural tissues (NTT). METHODS: A non‐targeted…